-
Barron's Picks And Pans: Activision, AT&T, Boeing, Ford, Nike, Square And More
Saturday, September 7, 2019 - 3:04pm | 677Read More...This weekend's Barron's offers three cheap stock picks for impatient investors. Other featured articles discuss how to play the alternative meat, athleisure and mobile gaming themes. Also, the prospects for an aerospace giant, a beleaguered drugmaker a mobile payments company and more....
-
Here's Why Barclays Downgraded Mallinckrodt
Wednesday, November 8, 2017 - 5:15pm | 439Read More...Specialty pharma company Mallinckrodt PLC (NYSE: MNK) reported disappointing results before the open Tuesday,with the weakness stemming from soft sales of its key drug Acthar, which fetched roughly 52 percent of the total sales. Acthar gel is an injectable formulation used to treat...
-
Mallinckrodt Exploring Potential $1 Billion Sale Of Its Nuclear Unit
Thursday, March 31, 2016 - 7:52am | 128Read More...Mallinckrodt PLC (NYSE: MNK) has hired advisers to explore a potential sale of its nuclear imaging division. Bloomberg, citing "people familiar with the matter," reported Mallinckrodt's division could fetch between $800 million and $1 billion in a potential deal. The publication...
-
EXCLUSIVE: Mallinckrodt Continues To Cooperate With Questcor-Related Government Investigations
Wednesday, March 16, 2016 - 12:52pm | 400Read More...In a Wednesday update to an earlier report, Probes Reporter dug into the potential impact of the ongoing multi-agency investigation of Mallinckrodt PLC (NYSE: MNK)’s Questcor Pharmaceuticals. The potential impact of the investigations is at the forefront of investors’ minds following...
-
Andrew Left Vs. Mallinckrodt CEO Debate Live On CNBC: What You Missed
Tuesday, March 15, 2016 - 6:07pm | 363Read More...Mallinckrodt PLC (NYSE: MNK) shares sold off 14 percent on Tuesday after Citron's Andrew Left compared the company -- again -- to Valeant Pharmaceuticals Intl Inc (NYSE: VRX). "Mkt. is starting to realize that $MNK equal risk to $VRX," Left tweeted around 2pm ET. Valeant finished...
-
Mallinckrodt Reports Better-Than-Expected Q1, Raises Guidance
Tuesday, February 2, 2016 - 8:54am | 263Read More...Shares of Mallinckrodt PLC (NYSE: MNK) were trading higher by nearly 6 percent early Tuesday morning after the company reported its first quarter results. Mallinckrodt earned $2.09 per share in the first quarter on revenue of $914.80 million. Wall Street analysts were expecting the company to...
-
Mixed Earnings Expectations For Merck And Pfizer
Sunday, January 31, 2016 - 8:21pm | 549Read More...Pharmaceutical giants Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE) are expected to post quarterly results this week. Analysts are looking for different top and bottom line results from each. A few other pharmaceutical and biotech companies are on deck this week as well. Two of...
-
John Paulson Puts Up Personal Holdings To Continue Longs In Greece, Puerto Rico & Mallinckrodt?
Tuesday, January 26, 2016 - 10:34am | 524Read More...John Paulson's hedge fund, Paulson & Co., entered into a few risky investments that didn't pay off, as noted by ZeroHedge, which resulted in heavy losses and many investors fleeing the fund. Paulson invested millions of dollars into Greece in hopes that the struggling economy would...
-
There's A Reason Mallinckrodt Continues To Disclose A Protracted, Multi-Agency Probe Of Recently-Acquired Questcor Pharmaceuticals
Tuesday, June 2, 2015 - 10:48am | 828Read More...Protracted SEC Investigation of Questcor Could Haunt Mallinckrodt Investors Facts of Interest or Concern: In Aug-2014, Mallinckrodt PLC (NYSE: MNK) completed its acquisition of Questcor Pharmaceuticals In a letter dated 23-Apr-2015, the SEC confirmed Questcor's involvement in on-going...
